Scholarlink

Objectives <p>To develop and validate a deep learning model for automated masseter muscle segmentation on routine head and neck CT and to evaluate whether the derived masseter muscle area is associated with overall survival in oral cancer.</p> Materials and methods <p>A U-Net-based model was trained using a model-development cohort (n = 348) with preoperative CT and bioelectrical impedance analysis. Masseter muscle area was measured on an axial slice at the maxillary sinus floor, and sex-specific cutoffs for low masseter muscle area were derived against sarcopenia defined by appendicular skeletal muscle index. Prognostic value of AI-derived masseter muscle area (AI-MMA) was tested in an independent cohort of primary oral cancer patients (n = 247) using Kaplan–Meier analysis and Cox proportional hazards models.</p> Results <p>Segmentation performance was high (Dice similarity coefficient, 0.92). AI-MMA correlated strongly with manual MMA in males and females (r = 0.892 and r = 0.896, respectively; both p &lt; 0.001). Low AI-MMA was associated with poorer overall survival. In multivariable analysis, low AI-MMA remained an independent predictor of mortality (hazard ratio [HR], 2.584; 95% CI, 1.132–5.898; p = 0.024), together with stage III–IV disease (HR, 5.811; 95% CI, 2.130–15.860; p &lt; 0.001) and low body mass index (HR, 2.572; 95% CI, 1.162–5.693; p = 0.020).</p> Conclusions <p>Automated AI-MMA from routine staging CT provides an objective prognostic biomarker in oral cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Deep learning-based automated masseter muscle area on routine CT stratifies survival in oral cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月11日

查看全文
  • Shin-ichiro Hiraoka,
  • Katsuya Sakamoto,
  • Kohei Kawamura,
  • Shuji Uchida,
  • Ryo Akiyama,
  • Susumu Tanaka

摘要

Objectives

To develop and validate a deep learning model for automated masseter muscle segmentation on routine head and neck CT and to evaluate whether the derived masseter muscle area is associated with overall survival in oral cancer.

Materials and methods

A U-Net-based model was trained using a model-development cohort (n = 348) with preoperative CT and bioelectrical impedance analysis. Masseter muscle area was measured on an axial slice at the maxillary sinus floor, and sex-specific cutoffs for low masseter muscle area were derived against sarcopenia defined by appendicular skeletal muscle index. Prognostic value of AI-derived masseter muscle area (AI-MMA) was tested in an independent cohort of primary oral cancer patients (n = 247) using Kaplan–Meier analysis and Cox proportional hazards models.

Results

Segmentation performance was high (Dice similarity coefficient, 0.92). AI-MMA correlated strongly with manual MMA in males and females (r = 0.892 and r = 0.896, respectively; both p < 0.001). Low AI-MMA was associated with poorer overall survival. In multivariable analysis, low AI-MMA remained an independent predictor of mortality (hazard ratio [HR], 2.584; 95% CI, 1.132–5.898; p = 0.024), together with stage III–IV disease (HR, 5.811; 95% CI, 2.130–15.860; p < 0.001) and low body mass index (HR, 2.572; 95% CI, 1.162–5.693; p = 0.020).

Conclusions

Automated AI-MMA from routine staging CT provides an objective prognostic biomarker in oral cancer.